[go: up one dir, main page]

EE04685B1 - Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks - Google Patents

Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks

Info

Publication number
EE04685B1
EE04685B1 EEP200000788A EEP200000788A EE04685B1 EE 04685 B1 EE04685 B1 EE 04685B1 EE P200000788 A EEP200000788 A EE P200000788A EE P200000788 A EEP200000788 A EE P200000788A EE 04685 B1 EE04685 B1 EE 04685B1
Authority
EE
Estonia
Prior art keywords
drug
matrix
rate
controlling membrane
membrane
Prior art date
Application number
EEP200000788A
Other languages
English (en)
Inventor
Jukarainen Harri
Markkula Tommi
Ala-Sorvari Juha
Lehtinen Matti
Ruohonen Jarkko
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of EE200000788A publication Critical patent/EE200000788A/et
Publication of EE04685B1 publication Critical patent/EE04685B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/10—Block- or graft-copolymers containing polysiloxane sequences
    • C08L83/12—Block- or graft-copolymers containing polysiloxane sequences containing polyether sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Silicon Polymers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Wrappers (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
EEP200000788A 1998-06-30 1999-06-11 Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks EE04685B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981506A FI107339B (fi) 1998-06-30 1998-06-30 Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
PCT/FI1999/000511 WO2000000550A1 (en) 1998-06-30 1999-06-11 A membrane or matrix for controlling the permeation rate of drugs

Publications (2)

Publication Number Publication Date
EE200000788A EE200000788A (et) 2002-04-15
EE04685B1 true EE04685B1 (et) 2006-08-15

Family

ID=8552104

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000788A EE04685B1 (et) 1998-06-30 1999-06-11 Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks

Country Status (28)

Country Link
EP (1) EP1124902B1 (et)
JP (1) JP2002519467A (et)
KR (1) KR100599868B1 (et)
CN (2) CN1269909C (et)
AR (1) AR018952A1 (et)
AT (1) ATE290049T1 (et)
AU (1) AU752895B2 (et)
BG (1) BG65148B1 (et)
BR (1) BR9911140B1 (et)
CA (1) CA2336149C (et)
CO (1) CO5060523A1 (et)
CZ (1) CZ299613B6 (et)
DE (1) DE69923992T2 (et)
EE (1) EE04685B1 (et)
ES (1) ES2237120T3 (et)
FI (1) FI107339B (et)
HU (1) HU229159B1 (et)
NO (1) NO327955B1 (et)
NZ (1) NZ508275A (et)
PE (1) PE20000935A1 (et)
PL (1) PL193485B1 (et)
PT (1) PT1124902E (et)
RU (1) RU2201794C2 (et)
SK (1) SK285325B6 (et)
TW (1) TWI237571B (et)
UA (1) UA71566C2 (et)
WO (1) WO2000000550A1 (et)
ZA (1) ZA200006986B (et)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
EP1438942A1 (en) * 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
CN101006124B (zh) * 2004-08-25 2010-11-24 联合碳化化学及塑料技术有限责任公司 聚合薄膜
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
BRPI0806311B1 (pt) 2007-03-12 2018-10-16 Bayer Schering Pharma Oy uso de tocoferol como um co-catalisador, métodos para manufaturar polímeros e elastômero de polisiloxano hidrófilo e polissiloxano hidrófilo resultante
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
US11992431B2 (en) 2008-09-17 2024-05-28 Bayer Oy Inserter
KR101612579B1 (ko) 2008-09-17 2016-04-14 베이어 오와이 삽입기
FI122579B (fi) 2010-10-29 2012-03-30 Bayer Oy Insertteri
CN102068914B (zh) * 2010-12-13 2012-10-10 大连欧科膜技术工程有限公司 一种气体分离复合膜的制备方法
CN102008909B (zh) * 2010-12-13 2012-10-10 大连欧科膜技术工程有限公司 一种气体分离复合膜的制备方法
CA2871001A1 (en) 2012-04-23 2013-10-31 Bayer Pharma Aktiengesellschaft Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one for treating uterine bleeding disorders
TW201350122A (zh) 2012-04-23 2013-12-16 Bayer Pharma AG １８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內用途，包含１８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內系統，及其於避孕及婦科治療之用途
CA2927750A1 (en) * 2013-10-18 2015-04-23 Bayer Oy Intrauterine delivery system
ES3009909T3 (en) 2015-05-13 2025-03-31 Bayer Oy Long acting drug delivery device in form of an implant or iud comprising levonorgestrel and ethinylestradiol
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
CA3085959A1 (en) 2017-12-22 2019-06-27 Alyra Biotech Pty Ltd Treatment of pain and/or pain related symptoms associated with dysmenorrhea
EP3536735B1 (de) * 2018-03-05 2020-10-14 Evonik Operations GmbH Vernetzte polyether-siloxan block-copolymere sowie deren verwendung zur herstellung von polyurethanschaumstoffen
CA3139771A1 (en) 2019-05-31 2020-12-03 Susan Florence Evans Methods, compositions and devices for treating neuroinflammatory conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889108A (en) * 1997-06-02 1999-03-30 Dow Corning Corporation Thickening solvents with elastomeric silicone polyethers

Also Published As

Publication number Publication date
DE69923992D1 (de) 2005-04-07
CZ20004749A3 (cs) 2001-10-17
AU752895B2 (en) 2002-10-03
AU4783999A (en) 2000-01-17
NZ508275A (en) 2002-09-27
PT1124902E (pt) 2005-07-29
BR9911140A (pt) 2001-03-06
ZA200006986B (en) 2001-05-23
KR100599868B1 (ko) 2006-07-12
SK285325B6 (sk) 2006-11-03
FI981506L (fi) 1999-12-31
EP1124902B1 (en) 2005-03-02
FI107339B (fi) 2001-07-13
PL193485B1 (pl) 2007-02-28
AR018952A1 (es) 2001-12-12
HUP0102600A3 (en) 2004-04-28
KR20010053346A (ko) 2001-06-25
EP1124902A1 (en) 2001-08-22
TWI237571B (en) 2005-08-11
FI981506A0 (fi) 1998-06-30
CO5060523A1 (es) 2001-07-30
CA2336149C (en) 2007-01-02
CN1488678A (zh) 2004-04-14
UA71566C2 (uk) 2004-12-15
CN1269909C (zh) 2006-08-16
CA2336149A1 (en) 2000-01-06
BG65148B1 (bg) 2007-04-30
RU2201794C2 (ru) 2003-04-10
CN1176999C (zh) 2004-11-24
CZ299613B6 (cs) 2008-09-17
NO20006581L (no) 2000-12-29
NO20006581D0 (no) 2000-12-21
HK1038939A1 (en) 2002-04-04
PE20000935A1 (es) 2000-09-18
CN1308653A (zh) 2001-08-15
BR9911140B1 (pt) 2009-08-11
DE69923992T2 (de) 2006-04-13
ES2237120T3 (es) 2005-07-16
EE200000788A (et) 2002-04-15
SK18942000A3 (sk) 2001-07-10
HUP0102600A2 (hu) 2001-11-28
JP2002519467A (ja) 2002-07-02
PL345103A1 (en) 2001-12-03
BG105081A (en) 2001-09-28
WO2000000550A1 (en) 2000-01-06
NO327955B1 (no) 2009-10-26
ATE290049T1 (de) 2005-03-15
HU229159B1 (hu) 2013-09-30

Similar Documents

Publication Publication Date Title
EE04685B1 (et) Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks
EE200100257A (et) Uudne membraan või maatriks ravimi läbitungimise kontrollimiseks
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
BR9710271A (pt) Matriz biológica ativa multiplexada
ID23874A (id) Obat
DE60037203D1 (de) Medikamentenspender
BR9913138B1 (pt) Derivado de quinolin-2-ona substituído com alquinila e composição farcêutica contendo o mesmo
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
NO20011085L (no) Tablett med umiddelbar frigivningsvirkning
IT1315841B1 (it) Catodo attivato e procedimento per la sua preparazione.
NO20000231D0 (no) Dolastatin-15-derivater
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
DK1036083T3 (da) Nye 9A-azalider
ID27150A (id) Sediaan levotiroksin bahan farmasi
ID29294A (id) Komposisi farmasi
MA26531A1 (fr) Composition pharmaceutique
DE69926012D1 (de) Arzneizubereitungen
BR9711559A (pt) Gel antimicÄtico com elevada libera-Æo de subst ncia de subst ncia ativa
NO308213B1 (no) Substituerte indanylidinacetylguanidiner, deres anvendelse og medikamenter inneholdende forbindelsene
ID25857A (id) Komposisi farmasi
DE59602953D1 (de) Fungizide wirkstoffkombinationen
DE59602890D1 (de) Fungizide wirkstoffkombinationen
DE69906934D1 (de) Arzneizubereitungen
FI961364L (fi) Lääkeainekoostumus

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20150611